EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
162 hedge funds and large institutions have $573M invested in Eagle Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 67 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
162
Holding in Top 10
2
Calls
$693K
Puts
–
Top Buyers
| 1 | +$5.53M | |
| 2 | +$2.4M | |
| 3 | +$1.47M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$1.32M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$815K |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$11.2M | |
| 3 | -$6.83M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$5.37M |
| 5 |
JPMorgan Chase & Co
New York
|
-$4.46M |